药明康德一季度归母净利润同比增长近9成 化学业务同比增幅达33%

每日经济新闻
28 Apr

每经记者 陈星 每经编辑 张益铭4月28日盘后,药明康德发布2025年一季报。报告期内,药明康德实现营业收入96.55亿元,同比增长20.96%;归属于上市公司股东的净利润36.72亿元,同比增长89.06%;扣非后归母净利润为23.29亿元,同比增长14.50%。药明康德在报告中表示,营收及归母净利润实现同比增长,主要得益于在保持营业收入增长的同时,不断优化生产工艺和经营效率,以及临床后期...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10